The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02078375
• Date of registration: 03/03/2014
• Prospective Registration: No
• Primary sponsor: Johns Hopkins University
• Public title: The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis PRESSRA
• Scientific title: The PRESS RA Study: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
• Date of first enrolment: February 2014
• Target sample size: 23
• Recruitment status: Terminated
• URL: https://clinicaltrials.gov/show/NCT02078375
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Double (Participant, Investigator).
• Phase: N/A

Countries of recruitment

United States

Contacts

• Name: Rebecca L. Manno, MD, MHS
• Affiliation: Johns Hopkins University

Key inclusion & exclusion criteria

Inclusion Criteria:

- age 60-95 years

- diagnosis of rheumatoid arthritis

- willing to participate in twice weekly exercise sessions

Exclusion Criteria:

- cognitive impairment

- recent heart surgery (within past 12 months)

- severe kidney disease

- use of supplemental oxygen

- presence of pacemaker

- diabetes that requires insulin for management

- allergy to soy or milk



Age minimum: 60 Years
Age maximum: 95 Years
Gender: All

Health Condition(s) or Problem(s) studied

Rheumatoid Arthritis

Intervention(s)

Dietary Supplement: Carbohydrate (Placebo)

Dietary Supplement: Protein

Other: Resistance Exercise Program

Primary Outcome(s)

Body composition [Time Frame: after 16 weeks]

Muscle strength [Time Frame: after 16 weeks]

Secondary ID(s)

NA_00088317

R03AG045081

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

National Institute on Aging (NIA)

American College of Rheumatology Research and Education Foundation